1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Demographic and clinical characteristics of patients who underwent vertebral stent placement with distal protection for treatment of symptomatic vertebral artery origin stenosis

Patient No./Age (y)/SexStroke SeverityCVD Risk FactorsLesion Length (mm)Lesion Stenosis and MorphologyStentLesion Stenosis (post)Sheath RemovalICU DaysTotal Hospital Days1 m MRS
1/71/MMajorHypertension, hyperlipidemia1.771%, regularBx VELOCITY Rx with Hepacoat 3.5 × 13 mm0%Manual compress112
2/64/MMajorHypertension, NIDDM, cigarette smoking672%, regularMulti-Link Zeta 3.5 × 13 mm5%Manual compress1143
3/78/FMajorHypertension, CAD466%, regularCYPHER 3.5 × 8 mm8%Manual compress113
4/81/MMinorHypertension, NIDDM, CAD472%, regularTAXUS 3.5 × 8 mm12%Perclose112
5/67/FMinorHypertension NIDDM, hyperlipidemia2.578%, regularTAXUS 3.5 × 8 mm3%Manual compress111
6/63/MMajorHypertenion, hyperlipidemia370%, regularTAXUS 3.5 × 13 mm5%Perclose1284
7/52/MMinorHypertension263%, regularTAXUS 3.5 × 8 mm Multi-Link Zeta 3.5 × 13 mm2%Perclose110
8/88/MMinorHypertension, hyperlipidemia, past cigarette smoking467%, regularTAXUS 3.5 × 12 mm2%Manual compress112
9/68/MMajorHypertension, hyperlipidemia, cigarette smoking771%, irregularCYPHER 3.5 × 23 mm7%Manual compress111
10/71/FMajorHypertension, NIDDM, hyperlipidemia0.568%, regularCYPHER 3.5 × 13 mm0%Manual compress194
11/59/MMajorHypertension, NIDDM, cigarette smoking2.582%, regularTAXUS 3.5 × 8 mm5%Manual compress113
12/58/MMajorHyperlipidemia, cigarette smoking374%, regularCYPHER 3.5 × 13 mm5%Perclose1104
  • Note:— CVD indicates cardiovascular disease; ICU, intensive care unit; MRS, Modified Rankin Scale; NIDDM, noninsulin-dependent diabetes mellitus; CAD, coronary artery disease.